AzTrials
AzTrials

ObesityNCT05917392

Effects of Kimchi Supplementation on Gut Microbiota, DNA Methylation and Serum Proteomes

A study testing Fermented Vegetables (Kimchi) supplementation, probiotic and polyphenol in people with Obesity, run by Mahidol University at 1 site in Thailand.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Participants will ask to answer questionnaire related to general characteristic, lifestyle, dietary pattern and undergo physical examination and measurement of body composition. The subjects will be divided into 2 groups: healthy control and intervention. Read more about this study

Who is it for?
Ages 35 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
Fermented Vegetables (Kimchi) supplementation, probiotic and polyphenol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteThailand
Study dates
15 Jun 2023to 31 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • age 35-50 years, BMI of ≥23 kg/m2, presence or absence of metabolic syndrome (not treated by medication) according to the National Cholesterol Education Program (NCEP ATPIII 2007), in collaboration with the International Diabetes Federation (IDF) and the World Health Organization (WHO), metabolic syndrome

Who cannot join

  • participants declined or withdrew, history of taking antibiotics in the 12 weeks prior to the project, history of using prebiotics or probiotic supplements on a regular basis, history of eating foods in these groups regularly, including yogurt, sour milk, fermented vegetables, and fermented fruits, history of taking drugs or weight loss products in the previous 6 months, history of diarrhea or constipation regularly, history of cure for ulcerative colitis, history of underlying disease that requires continuous medication, history of taking laxatives regularly, history of severe gastrointestinal disease, and history of illnesses such as thyroid disease, cancer, autoimmune diseases, kidney disease and hypertension etc.

Trial locations and contacts

1 site in 1 country.

Jintana Sirivarasai, Ph.D contact

662-201-1483

jintana.sir@mahidol.ac.th

Prapimporn Chattranukulchai, MD contact

662-201-1922

sprapimporn@gmail.com

Thailand1 site
  • Jintana Sirivarasai

    Bangkok, 10400

    Jintana Sirivarasai, Ph.D, 662-201-1483, jintana.sir@mahidol.ac.th

    Prapimporn Chattranukulchai, MD., 662-201-1992, sprapimporn@gmail.com

Other trials in Thailand

About this study

Official title: Effects of Polyphenol and Lactobacillus Rhamnosus Supplementation in Fermented Vegetables (Kimchi) on Gut Microbiota, DNA Methylation and Serum Proteomes in Overweight and Obese Women

Participants will ask to answer questionnaire related to general characteristic, lifestyle, dietary pattern and undergo physical examination and measurement of body composition. The subjects will be divided into 2 groups: healthy control and intervention. The intervention group was divided into 3 subgroups: the fermented vegetable (kimchi) group, the kimchi supplemented with polyphenol (Vitexin) group, or the kimchi supplemented with probiotic (Lactobacillus rhamnosus) group. The intervention group will be instructed to consume 1 pack of kimchi per day (50 g/pack) with lunch for 2 months.

Read the detailed description

The subjects will be divided into 2 groups: healthy control and intervention. The intervention group was divided into 3 subgroups: the fermented vegetable (kimchi) group, the kimchi supplemented with polyphenol (Vitexin) group, or the kimchi supplemented with probiotic (Lactobacillus rhamnosus) group. The intervention group will be instructed to consume 1 pack of kimchi per day (50 g/pack) with lunch for 2 months. During the study, participants will be strongly encouraged to avoid consuming prebiotics or probiotic supplements, as well as foods such as yogurt, sour milk, fermented vegetables, and fermented fruits, especially 2 weeks before the blood and fecal examination. Compliance will be assessed by monitoring product side effects through follow-up phone calls every week to check on participants' symptoms and assessing the number of sachets or packs they actually consume.

Conditions
Obesity
Being tested
Fermented Vegetables (Kimchi) supplementation, probiotic, polyphenol
Keywords
DNA methylation, proteomic, microbiota
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fermented Vegetables (Kimchi) supplementationDietary supplement

    Also called Kimchi supplementation

    Fermented Vegetables (Kimchi) supplementation with 50 gm daily for two months and effects of DNA methylation, serum proteome and microbiota

  • probioticDietary supplement

    Supplementation with Kimchi plus LGG 50 grams daily for two months

  • polyphenolDietary supplement

    Supplementation with Kimchi plus polyphenol 50 grams daily for two months

Study groups in NCT05917392
Study groupRoleWhat they receive
Supplementation-standardActive comparatorSupplementation with Kimchi 50 gram daily for two months
Receives: Dietary Supplement: Fermented Vegetables (Kimchi) supplementation
Supplementation with probioticExperimentalSupplementation with Kimchi plus LGG 50 gram daily for two months
Receives: Dietary Supplement: probiotic
Supplementation with polyphenolExperimentalSupplementation with Kimchi plus polyphenol 50 gram daily for two months
Receives: Dietary Supplement: polyphenol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ฺBMI

    changes in BMI for evaluating obesity at 2 months from baseline

    Measured: 2 months

  2. gut bacterial flora

    Changes and differences of the gut bacterial flora will be addressed in detail, e.g. changes in concentration of specific bacterial groups (e.g. Lactobacillus) before and after the intervention period.

    Measured: 2 months

Secondary outcomes (2)
  1. DNA methylation of inflammation and anti-inflammation gene

    changes in methylation (hypomethylation and hypermethylation)

    Measured: 2 months

  2. Serum proteome

    changes in protein expression (up and dow-regulation)

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2023
  2. Study start15 Jun 2023 (estimated)
  3. Primary completion30 Nov 2023 (estimated)
  4. Study completion31 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05917392
Sponsor's protocol ID
COA. MURA2023/127
Status last verified
Jun 2023
First submitted
21 May 2023
Last updated
23 Jun 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all IPD that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing Fermented Vegetables (Kimchi) supplementation, probiotic and polyphenol in people with Obesity, run by Mahidol University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jintana Sirivarasai, Ph.D (662-201-1483, jintana.sir@mahidol.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ฺBMI (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in